全文获取类型
收费全文 | 5324篇 |
免费 | 185篇 |
国内免费 | 63篇 |
出版年
2023年 | 12篇 |
2022年 | 47篇 |
2021年 | 82篇 |
2020年 | 22篇 |
2019年 | 9篇 |
2018年 | 35篇 |
2017年 | 31篇 |
2016年 | 327篇 |
2015年 | 1143篇 |
2014年 | 1449篇 |
2013年 | 238篇 |
2012年 | 315篇 |
2011年 | 280篇 |
2010年 | 183篇 |
2009年 | 113篇 |
2008年 | 125篇 |
2007年 | 100篇 |
2006年 | 72篇 |
2005年 | 131篇 |
2004年 | 154篇 |
2003年 | 115篇 |
2002年 | 85篇 |
2001年 | 81篇 |
2000年 | 42篇 |
1999年 | 28篇 |
1998年 | 19篇 |
1997年 | 21篇 |
1996年 | 13篇 |
1995年 | 8篇 |
1994年 | 9篇 |
1993年 | 36篇 |
1992年 | 29篇 |
1991年 | 14篇 |
1990年 | 19篇 |
1989年 | 25篇 |
1988年 | 11篇 |
1987年 | 8篇 |
1986年 | 14篇 |
1985年 | 27篇 |
1984年 | 4篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1980年 | 4篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1973年 | 5篇 |
1966年 | 3篇 |
1957年 | 6篇 |
1955年 | 4篇 |
1943年 | 3篇 |
排序方式: 共有5572条查询结果,搜索用时 437 毫秒
101.
102.
103.
104.
105.
106.
107.
108.
Jason S. Haukoos Jonathan D. Campbell Amy A. Conroy Emily Hopkins Meggan M. Bucossi Comilla Sasson Alia A. Al-Tayyib Mark W. Thrun For the Denver ED HIV Opt-Out Study Group 《PloS one》2013,8(12)
Background
The Centers for Disease Control and Prevention recommends nontargeted opt-out HIV screening in healthcare settings. Cost effectiveness is critical when considering potential screening methods. Our goal was to compare programmatic costs of nontargeted opt-out rapid HIV screening with physician-directed diagnostic rapid HIV testing in an urban emergency department (ED) as part of the Denver ED HIV Opt-Out Trial.Methods
This was a prospective cohort study nested in a larger quasi-experiment. Over 16 months, nontargeted rapid HIV screening (intervention) and diagnostic rapid HIV testing (control) were alternated in 4-month time blocks. During the intervention phase, patients were offered HIV testing using an opt-out approach during registration; during the control phase, physicians used a diagnostic approach to offer HIV testing to patients. Each method was fully integrated into ED operations. Direct program costs were determined using the perspective of the ED. Time-motion methodology was used to estimate personnel activity costs. Costs per patient newly-diagnosed with HIV infection by intervention phase, and incremental cost effectiveness ratios were calculated.Results
During the intervention phase, 28,043 eligible patients were included, 6,933 (25%) completed testing, and 15 (0.2%, 95% CI: 0.1%–0.4%) were newly-diagnosed with HIV infection. During the control phase, 29,925 eligible patients were included, 243 (0.8%) completed testing, and 4 (1.7%, 95% CI: 0.4%–4.2%) were newly-diagnosed with HIV infection. Total annualized costs for nontargeted screening were $148,997, whereas total annualized costs for diagnostic HIV testing were $31,355. The average costs per HIV diagnosis were $9,932 and $7,839, respectively. Nontargeted HIV screening identified 11 more HIV infections at an incremental cost of $10,693 per additional infection.Conclusions
Compared to diagnostic testing, nontargeted HIV screening was more costly but identified more HIV infections. More effective and less costly testing strategies may be required to improve the identification of patients with undiagnosed HIV infection in the ED. 相似文献109.
Sumit Mohan Edwin Huff Jay Wish Michael Lilly Shu-Cheng Chen William M. McClellan for the Fistula First Breakthrough Initiative Data Committee 《PloS one》2013,8(12)
Background
Patients started on long term hemodialysis have typically had low rates of reported renal recovery with recent estimates ranging from 0.9–2.4% while higher rates of recovery have been reported in cohorts with higher percentages of patients with acute renal failure requiring dialysis.Study Design
Our analysis followed approximately 194,000 patients who were initiated on hemodialysis during a 2-year period (2008 & 2009) with CMS-2728 forms submitted to CMS by dialysis facilities, cross-referenced with patient record updates through the end of 2010, and tracked through December 2010 in the CMS SIMS registry.Results
We report a sustained renal recovery (i.e no return to ESRD during the available follow up period) rate among Medicare ESRD patients of > 5% - much higher than previously reported. Recovery occurred primarily in the first 2 months post incident dialysis, and was more likely in cases with renal failure secondary to etiologies associated with acute kidney injury. Patients experiencing sustained recovery were markedly less likely than true long-term ESRD patients to have permanent vascular accesses in place at incident hemodialysis, while non-White patients, and patients with any prior nephrology care appeared to have significantly lower rates of renal recovery. We also found widespread geographic variation in the rates of renal recovery across the United States.Conclusions
Renal recovery rates in the US Medicare ESRD program are higher than previously reported and appear to have significant geographic variation. Patients with diagnoses associated with acute kidney injury who are initiated on long-term hemodialysis have significantly higher rates of renal recovery than the general ESRD population and lower rates of permanent access placement. 相似文献110.
Nabil Azhar Cordelia Ziraldo Derek Barclay David A. Rudnick Robert H. Squires Yoram Vodovotz for the Pediatric Acute Liver Failure Study Group 《PloS one》2013,8(11)